DL-3-n-butylphthalide
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DL-3-n-butylphthalide, covering 2016-05-18 to 2024-07-18. Get the full timeline:
Most recent: Clinical Trial Update: Effects of DL-3-n-butylphthalide on Chemotherapy-Induced Cognitive Impairment [Phase 4]